# Malaria chemoprophylaxis: cross-sectional study of use among air travellers departing from Accra, Ghana

**Authors:** Henry J.O. Lawson, Gerhard K. Ofori-Amankwah, Akye Essuman, Edwina B. Opare-Lokko, Charles Antwi-Boasiako, Andrew A. Adjei

PMC · DOI: 10.5281/zenodo.10756885 · MalariaWorld Journal · 2017-02-28

## TL;DR

This study examines how air travelers in Accra, Ghana use malaria chemoprophylaxis, finding that most use atovaquone/proguanil with high compliance and low side effects.

## Contribution

The study provides new data on chemoprophylaxis use, effectiveness, and costs among travelers departing from Accra, Ghana.

## Key findings

- Atovaquone/proguanil was the most commonly used chemoprophylaxis (34.9%).
- Malaria incidence among travelers was 7.1%, with most cases treated in hospitals or clinics.
- High compliance (73.8%) and low side effects were reported among users.

## Abstract

Malaria is the most common life-threatening infectious disease among travellers and chemoprophylaxis is recommended. The overall effectiveness, medication types and cost of malaria chemoprophylaxis in Accra are not well documented. This study investigated the use of chemoprophylaxis for malaria prevention in air travellers departing from Kotoka International Airport (KIA) in Accra, Ghana.

A cross-sectional study was conducted in the departure lounge of the KIA between February and May 2012. A total of 424 respondents voluntarily completed a semi-structured questionnaire, which included socio-demographic characteristics, duration of stay, nationality, country of permanent residence, chemoprophylaxis used, number of doses missed, cost and side effects experienced, and cost of treatment.

The mean age of respondents was 37 ± 0.84 years with a male:female ratio of 1.2:1.The mean duration of stay in Ghana was 47.9 days [SD 56.8] and 73.5% had made one trip to the country in the preceding year. Of the respondents, 50.7% were from Europe, 24.1% from North America and 17.5% from Africa. The most popular malaria prevention method used was prophylactics (37%) with atovaquone/proguanil used most frequently (34.9%), followed by mefloquine (11.6%) and doxycycline (7.8%). Compliance was high: 73.8% of respondents did not miss a single dose. The most commonly reported side effects were dreams, abdominal discomfort and headaches. Malaria incidence was 7.1% with 80% of them receiving treatment in a hospital or clinic; incurring a cost of up to $30 to treat a person.

Most air travellers from Accr a take atovaquone/pr oguanil. Malaria incidence was low and most travellers were compliant with their chemoprophylaxis with very few side effects. The cost of chemoprophylaxis is low and is thus recommended for all travellers to Accra, Ghana.

## Linked entities

- **Chemicals:** atovaquone (PubChem CID 74989), proguanil (PubChem CID 4923), mefloquine (PubChem CID 4046), doxycycline (PubChem CID 54671203)
- **Diseases:** malaria (MONDO:0005136)

## Full-text entities

- **Diseases:** abdominal discomfort (MESH:D000007), headaches (MESH:D006261), Malaria (MESH:D008288), infectious disease (MESH:D003141)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11003205/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11003205/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC11003205/full.md

---
Source: https://tomesphere.com/paper/PMC11003205